The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).

The Food and Drug Administration (FDA) would like you to check if you have any broccoli in your freezer, as it may be part of a serious recall. On December 31, the (FDA) published a recall notice for ...